Cargando…

Anti-angiogenic drug scheduling optimisation with application to colorectal cancer

Bevacizumab (bvz) is a first choice anti-angiogenic drug in oncology and is primarily administered in combination with chemotherapy. It has been hypothesized that anti-angiogenic drugs enhance efficacy of cytotoxic drugs by “normalizing” abnormal tumor vessels and improving drug penetration. Neverth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sturrock, M., Miller, I. S., Kang, G., Hannis Arba’ie, N., O’Farrell, A. C., Barat, A., Marston, G., Coletta, P. L., Byrne, A. T., Prehn, J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060139/ https://www.ncbi.nlm.nih.gov/pubmed/30046049 http://dx.doi.org/10.1038/s41598-018-29318-5

Ejemplares similares

Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
por: Sturrock, M., et al.
Publicado: (2018)

Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background
por: Eng, Zing Hong, et al.
Publicado: (2023)

Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer
por: Cao, Mengyuan, et al.
Publicado: (2022)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties
por: Etulain, Julia, et al.
Publicado: (2018)

Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta
por: Uyanıkoğlu, Hacer, et al.
Publicado: (2018)

Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer
por: Lim, Yoojoo, et al.
Publicado: (2015)

Pre-screening the intrinsic angiogenic capacity of biomaterials in an optimised ex ovo chorioallantoic membrane model
por: Kohli, Nupur, et al.
Publicado: (2020)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

OptorSim: a Simulation Tool for Scheduling and Replica Optimisation in Data Grids
por: Nicholson, C, et al.
Publicado: (2005)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Evidence for a weak angiogenic response to human colorectal cancers.
por: Pritchard, A. J., et al.
Publicado: (1995)

Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
por: Murphy, Con, et al.
Publicado: (2018)

Reversibility in dynamics and group theory
por: O'Farrell, A G, et al.
Publicado: (2014)

Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models
por: El-Emir, E, et al.
Publicado: (2007)

Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action
por: Quayle, Lewis A., et al.
Publicado: (2017)

Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
por: Pasquier, Eddy, et al.
Publicado: (2012)

Recent Advances in Anti-Angiogenic Therapy of Cancer
por: Samant, Rajeev S., et al.
Publicado: (2011)

Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
por: Kiss, Elina A., et al.
Publicado: (2019)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?
por: Hochster, H S
Publicado: (2013)

Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti‐angiogenic therapies
por: Lazaris, Anthoula, et al.
Publicado: (2018)

Anti-angiogenic therapy with contrast-enhanced ultrasound in colorectal cancer patients with liver metastasis
por: Wu, Zhiyong, et al.
Publicado: (2017)

Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
por: O'Farrell, Eoin, et al.
Publicado: (2019)

Introduction to Maple programming
por: O'Farrell, Anthony G
Publicado: (2005)

Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
por: Wohlfeil, Sebastian A., et al.
Publicado: (2022)

Integrating Colon Cancer Microarray Data: Associating Locus-Specific Methylation Groups to Gene Expression-Based Classifications
por: Barat, Ana, et al.
Publicado: (2015)

Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
por: Totterdell, James A., et al.
Publicado: (2022)

Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors
por: Otjacques, Eléonore, et al.
Publicado: (2013)

Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors
por: Marek-Trzonkowska, Natalia, et al.
Publicado: (2015)

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2015)

Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene
por: Cárdenas, Casimiro, et al.
Publicado: (2011)

The promise of anti-angiogenic cancer therapy
por: Oehler, M K, et al.
Publicado: (2000)

Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Limitations of Anti-Angiogenic Treatment of Tumors
por: Ribatti, Domenico, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h70t5dpna8bcb3dsaagf1a6g6a